A study led by Professor Sergio Quezada and Professor Karl Peggs (both UCL Cancer Institute) has identified how a subset of immune cells are activated to kill cancerous cells, a finding which could hold the key to new powerful therapies against the disease.
Read: Mail Online, More: Sky News, Mirror, UCL News
Close
